SecBot SecBot
PRESS-RELEASE ·Filed Apr 29, 2026

VCNX

Vaccinex, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Monitor for upcoming clinical trial catalysts or financing events; no immediate trading signal from this earnings release.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.7800
T+0 close · Apr 29, 2026 · via day close
Latest settled
+51.28%
T+60 · $1.18
Vs SPY
+48.17%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 30 $0.7800entry
  2. T+1 · 7mo ago +28.21%α +27.99% · $1.00
  3. T+5 · 6mo ago +29.49%α +27.76% · $1.01
  4. T+20 · 6mo ago +28.21%α +22.98% · $1.00
  5. T+60 · 4mo ago +51.28%α +48.17% · $1.18

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vaccinex released financial results for the year ended December 31, 2025, reporting an EPS of -$1.09 for Q3 2023, which was in line with consensus estimates. As a clinical-stage biotech with no revenue, the filing is routine and lacks material financial surprises or guidance changes.

Key Financial Metrics

EPS
−$1.09
Revenue
$0.00
est $0.00
Rating
in line

Key Facts

  • EPS of -$1.09 for Q3 2023, in line with consensus
  • No revenue reported for the period
  • Clinical-stage company with no approved products or revenue stream
  • Financial statements posted on company website

Financial Impact

No material financial impact; clinical-stage biotech with no revenue and EPS in line with expectations

eps

Risk Factors

  • No revenue or near-term commercialization path
  • Dependence on future financing for clinical development

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3284388

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026